This inventor holds 3 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignees: Sunesis Pharmaceuticals, Inc., Biogen Ma Inc., Millenium Pharmaceuticals, Inc.. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 63 
1 out of 269 
1 out of 36 
Years Active: 2017-2021
Title: Kurt D Van Vloten: Innovator in Pharmaceutical Compounds
Introduction
Kurt D Van Vloten is a notable inventor based in Bellingham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. With a total of 3 patents, his work has implications for treating various diseases.
Latest Patents
One of his latest patents is for an NRF2 activator, which includes compounds of Formula I and their pharmaceutically acceptable salts, along with methods for their use and production. Another significant invention involves heterocyclic compounds that serve as PDK1 inhibitors. This patent provides compounds useful as inhibitors of PDK1, along with compositions and methods for treating PDK1-mediated diseases.
Career Highlights
Kurt has worked with prominent companies in the pharmaceutical industry, including Sunesis Pharmaceuticals, Inc. and Millennium Pharmaceuticals, Inc. His experience in these organizations has allowed him to contribute to innovative research and development in drug discovery.
Collaborations
Throughout his career, Kurt has collaborated with talented individuals such as Edward Yin-Shiang Lin and Joseph Arndt. These partnerships have enhanced his research efforts and led to the advancement of his inventions.
Conclusion
Kurt D Van Vloten's work in pharmaceutical innovations showcases his dedication to improving healthcare through targeted therapies. His patents reflect a commitment to addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile